Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Physical activity, height, and smoking affect prostate cancer risk.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Finasteride reduces prostate size and PSA levels in young patients.

Tamoxifen effectively treats gynecomastia without causing impotence.

Using finasteride with TIP extends time off period for prostate cancer patients.

Finasteride affects prostate weights and pituitary activity differently with age.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Mutations in certain receptors can cause diseases and offer new treatment options.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.